The number of people with keratoconus disorder is going up around the world. This increase means there's a higher demand for treatments like lenses, surgeries, corneal cross-linking, and more. According to the American Journal of Ophthalmology, 50 to 200 out of every 100,000 people have keratoconus. In the US, a study showed that 54.5 out of every 100,000 people have it. Overall, about 3 million people worldwide have this disorder.
As the number of keratoconus cases rises, more people are turning to different treatments like intacs and corneal transplant. These treatments work well because they lower the risk of losing vision and make patients more comfortable. This is why the market for keratoconus treatments is growing.
The keratoconus disorder is becoming more common, and this is a concern worldwide. This eye condition affects the cornea, the clear front part of the eye. When someone has keratoconus, their cornea becomes thin and starts to bulge like a cone. This can cause vision problems, like blurry or distorted vision.
To tackle these vision issues, people with keratoconus often seek different treatments. One option is using special lenses to improve vision. Another option is surgery, where the cornea is reshaped to correct the bulging. Corneal cross-linking is a treatment that strengthens the cornea to stop it from getting worse. These treatments are crucial in managing keratoconus and preventing further vision loss.
Recent data from the American Journal of Ophthalmology indicates that the number of people dealing with keratoconus is rising. The range is between 50 to 200 cases for every 100,000 people. In the United States, the prevalence is approximately 54.5 cases per 100,000 people. When we look at the global scale, around 3 million people are currently affected by this eye condition. This increase in cases has led to a higher demand for treatments.
The growth in the number of keratoconus cases has a direct impact on the use of various treatment methods. Intacs and corneal transplant are two such methods gaining popularity. Intacs are small devices implanted in the cornea to provide structural support, and corneal transplant involves replacing the damaged cornea with a healthy one from a donor. Both these methods are effective in reducing the risk of vision loss and improving the overall comfort of patients.
The rise in demand for these treatments is contributing to the expansion of the market for keratoconus management. People with this disorder are actively seeking solutions to improve their vision and enhance their quality of life. The availability of effective treatment options gives hope to those affected by keratoconus, as it means they have viable ways to address their vision challenges.
In conclusion, the increasing incidence and prevalence of keratoconus are driving the need for various treatment options. From lenses to surgeries, the market for managing keratoconus is expanding to meet the growing demand. As more people around the world are diagnosed with this disorder, the importance of accessible and effective treatments becomes even more critical in ensuring a better quality of life for those affected by keratoconus.
Covered Aspects:Report Attribute/Metric | Details |
---|---|
Market Opportunities | · Growing R&D activities in the healthcare industry |
Market Dynamics | · Increase in cases of eyes disorders and overexposure of sunlight |
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)